Showing results (351-360 of 790) with videos related to

Sort By:
Pageof 79
Nature Medicine|October 27, 2004
The RAB25 small GTPase determines aggressiveness of ovarian and breast cancersKwai Wa Cheng, John P Lahad, Wen-Lin Kuo, et al.
Bioinformatics (Oxford, England)|October 7, 2022
RPPA SPACE: an R package for normalization and quantitation of Reverse-Phase Protein Array dataHuma Shehwana, Shwetha V Kumar, James M Melott, et al.
Cancer Research|December 16, 2014
α-Tubulin acetylation elevated in metastatic and basal-like breast cancer cells promotes microtentacle formation, adhesion, and invasive migrationAmanda E Boggs, Michele I Vitolo, Rebecca A Whipple, et al.
Cancer Research|April 15, 2010
Mammalian target of rapamycin activator RHEB is frequently overexpressed in human carcinomas and is critical and sufficient for skin epithelial carcinogenesisZhi Hong Lu, Mark B Shvartsman, Andrew Y Lee, et al.
Scientific Reports|February 14, 2019
Niraparib activates interferon signaling and potentiates anti-PD-1 antibody efficacy in tumor modelsZebin Wang, Kaiming Sun, Yonghong Xiao, et al.
Nature Communications|August 30, 2017
Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug responseIoannis K Zervantonakis, Claudia Iavarone, Hsing-Yu Chen, et al.
Nature Biotechnology|July 5, 2022
A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugsZuzana Tatarova, Dylan C Blumberg, James E Korkola, et al.
Cancer Research|January 4, 2008
A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activityJoseph R Garlich, Pradip De, Nandini Dey, et al.
BMC Medicine|February 2, 2023
PMCA inhibition reverses drug resistance in clinically refractory cancer patient-derived modelsKi Cheong Park, Jung Min Kim, Sang Yong Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2016
High Intratumoral Stromal Content Defines Reactive Breast Cancer as a Low-risk Breast Cancer SubtypeJennifer B Dennison, Maria Shahmoradgoli, Wenbin Liu, et al.
Pageof 79